CFMG & Wellpath in California — a documentary investigation · Article 002 of 100 · Series 1 — Corporate history and the making of an enterprise

December 31, 2012: The Agreement That Rebuilt CFMG Around an MSO

Published

20 September 2026, 6:00 PM PT

Content last changed

20 September 2026, 6:00 PM PT

Public-evidence cutoff

20 September 2026, 6:00 PM PT

Sources checked

20 September 2026, 6:00 PM PT

Record through

20 September 2026, 6:00 PM PT

Editorial status

Public-source editorial review complete

Evidence note. This article relies on public records and distinguishes established fact, party position, allegation, judicial finding, inference and unresolved question. Nothing here is a finding that any identified corporation or individual violated California law unless a cited adjudicative source expressly says so.

Opening frame#

December 31, 2012: The Agreement That Rebuilt CFMG Around an MSO is fundamentally an identity-and-continuity inquiry. The legal entity, the management platform, the public brand, and the county-facing operation may overlap without becoming interchangeable. The analysis therefore asks what changed, what persisted, and which primary records are capable of proving each proposition.

The governing question is narrow: How did the 2012 MSA divide professional authority from management power? The article connects that question to juridical identity, operational integration, professional authority, ownership and succession, practical exit rights, and demonstrated veto power only where the evidence makes those connections material.

I. The Question and the Public Record#

The relevant public record is best read cumulatively. No single branding statement, county agenda item, corporate filing, bankruptcy disclosure, or management agreement resolves the entire relationship. The evidentiary value comes from comparing documents created for different purposes and asking whether they converge on the same allocation of identity, authority, economics, and professional responsibility.

Very high confidence#

• CFMG is legally distinct from Wellpath LLC and WMI.

• CFMG remained active after Chapter 11.

• CFMG remains a County contractor and current labor-law employer in material California operations.

• Wellpath provides deep management infrastructure.

• The MSA formally reserves important professional functions to CFMG.

• Genuine physician leadership exists within CFMG.

• Wellpath enterprise quality/clinical infrastructure is substantive.

• Bankruptcy forced entity clarification and exposed integration.

• Public branding and corporate identity diverged enough to create real institutional confusion.

The december 31, 2012 MSA reveals a different corporate title for dan hustedt#

The execution page of the 2012 MSA contains one of the most significant governance facts in the public record.

The agreement is signed on behalf of:

California Forensic Medical Group, Incorporated — THE COMPANY

by:

Dan Hustedt, its Chief Executive Officer

and on behalf of:

California Forensic Management Group, Inc. — THE MANAGEMENT COMPANY

by:

Dan Hustedt, its Chief Executive Officer

Thus the same individual signed both sides of the MSA as CEO of each corporation .

This is primary documentary evidence.

It should neither be minimized nor exaggerated.

II. Structural and Historical Context#

From CFMG to the Wellpath Era: A California Corporate Timeline#

The modern CFMG–Wellpath structure is easier to understand when three histories are kept separate: the history of the California professional corporation, the history of the management enterprise around it, and the history of government contracts that continued through those changes.

A common mistake is to tell the story as a straight corporate succession:

CFMG → CMGC → Wellpath

The public documents do not support treating that shorthand as a complete legal genealogy.

A better model is three parallel tracks.

2019: the CFMG management agreement moves to Wellpath LLC#

The next public document is more precise.

Effective January 1, 2019, the parties executed an Assignment of Management Services Agreement .

The document identifies:

• California Forensic Medical Group, Inc. as the Company ;

• Wellpath LLC as the Manager ; and

• Wellpath Management, Inc., with its predecessor names, as the Outgoing Manager .

The assignment says the October 2018 corporate transaction made the entities affiliates and states that the MSA was being transferred to Wellpath LLC for efficiency in administering management functions. 2019 Assignment

That document is one of the clearest public markers of the transition into the Wellpath era.

It is also significant for another reason: the assignment states that the MSA was transferred together with related or incidental instruments, including relevant stock-transfer restriction agreements .

The assignment proves that such instruments were part of the transaction documents or related contractual architecture.

It does not reveal their operative terms.

That makes the underlying CFMG-specific stock-transfer and succession documents an important open-source target rather than a basis for speculation.

III. The Control and Governance Analysis#

Why the 2012 management agreement matters#

The most revealing public document is CFMG’s December 31, 2012 Management Services Agreement, filed as an exhibit in Wellpath’s bankruptcy.

The agreement expressly says CFMG is a California professional corporation engaged in professional medical services. It describes CFMG and the management company as independent contractors and states that CFMG is solely and exclusively in control of professional medical services. At the same time, it makes the management company the exclusive provider of defined management services and assigns it extensive administrative responsibilities. Source: CFMG Management Services Agreement

That document is not a smoking gun for either side.

It is evidence of a deliberately layered system.

The formal model is:

CFMG — professional medical corporation

Management company / later Wellpath LLC — administrative and management infrastructure

The investigative question is whether actual operations followed the formal allocation when a matter reached a decision California reserves to physicians.

The central thesis of this investigation#

The public record supports two propositions at the same time:

CFMG remains legally meaningful as a California professional corporation and public contractor.

and

Wellpath supplies a broad operating and management architecture around CFMG.

The next question is not whether those facts can coexist. They plainly can.

The next question is how authority moves through the system.

This series will trace that question across:

• corporate history;

• the management agreement;

• California corporate-practice law;

• county contracts;

• employment and HR systems;

• physician staffing;

• credentialing and privileging;

• medical records;

• utilization and referrals;

• clinical policy;

• finance and banking;

• insurance and claims;

• litigation positions;

• bankruptcy;

• and county-by-county operations.

Where the public record proves something, the investigation will say so.

Where it proves only an allegation, stipulation, company position, or administrative fact, that distinction will remain visible.

And where the public record does not establish who had the final authority, the answer will be open rather than inferred.

The 2012 MSA: professional corporation and management company#

One day before the calendar turned to 2013, CFMG entered a detailed Management Services Agreement with California Forensic Management Group, Inc., a Delaware corporation.

The contract describes two separate roles:

• CFMG as the California professional corporation providing medical services; and

• the management company as the provider of defined management and administrative services.

The agreement states that the entities are independent contractors and reserves professional medical services to CFMG. It also gives the management company a broad portfolio of administrative responsibilities. CFMG Management Services Agreement

This contract is the foundation for understanding the later Wellpath relationship.

Inside the CFMG–Wellpath Management Architecture#

The 2012 CFMG Management Services Agreement is unusually revealing. It formally reserves professional medicine to CFMG while assigning the management company a wide operating role across employment, finance, records, information systems, insurance, claims and other administrative functions. The contract therefore supports both professional separation and deep operational integration.

Many discussions of management-services organizations fail because they start with a conclusion.

Either the MSO is described as a routine back-office vendor, or its broad involvement is treated as proof that it controls the medical practice.

CFMG’s publicly filed management agreement makes both shortcuts difficult.

The contract contains unusually explicit language protecting physician authority.

It also gives the manager unusually broad responsibilities.

The document is therefore best read as an authority map .

Layer seven: finance and cash management#

The agreement also creates substantial financial integration.

The management-services package includes:

• accounting;

• financial reporting;

• invoicing;

• payroll/tax support;

• budgeting;

• cash management;

• benefit and bonus-plan administration.

Exhibit D provides for a management fee calculated as a percentage of adjusted gross revenues — identified in the filed version as 18% — and states that the parties regarded the fee as fair-market-value compensation for management services.

The same exhibit authorizes specified disbursement mechanics and grants the management company a security interest in CFMG assets to the extent permitted by law, with references to broader credit arrangements.

These are economically important provisions.

They are not, by themselves, proof of professional control.

But they make separate questions worth investigating:

• How economically dependent was CFMG on the management structure?

• What happened if the management agreement ended?

• What did the referenced deficit-funding and credit documents provide?

• Could financial remedies affect the practical ability to change managers?

Those questions require the related contracts, not inference from the MSA alone.

Pre-Wellpath foundation#

Early 1980s. CFMG develops as a California correctional-health provider. The historical corporation predates modern Wellpath branding by decades.

December 31, 2012. CFMG enters the Management Services Agreement that becomes the structural spine of the modern investigation. The MSA formally reserves professional medical authority to CFMG while granting a separate manager extensive exclusive administrative, financial, HR, records, IT, contracting, insurance, billing, compliance, and related functions.

January 2013. H.I.G. publicly announces a strategic investment in the enterprise associated with CFMG/CMGC. The public record supports private-equity entry at the enterprise level but does not, by itself, prove H.I.G. directly acquired CFMG physician shares.

Enterprise consolidation#

2015–2017. Raymond Herr, M.D. becomes publicly visible as CFMG President/CMO and authorized official. Litigation and County records later connect him to finance, contracts, staffing, policies, LVN scope, and mortality-review evidence.

October 1, 2018. H.I.G. combines Correct Care Solutions and its CMGC platform, creating the enterprise that becomes Wellpath. This is an enterprise combination; it does not establish that the California professional corporation merged out of existence.

January 1, 2019. The CFMG MSA and related/incidental instruments are assigned to Wellpath LLC. The assignment expressly references relevant stock-transfer restriction agreements. This is the strongest CFMG-specific proof that ownership/succession instruments existed, but not proof of their contents.

California Forensic Medical Group, Inc. (CFMG)#

The central California professional corporation. Current evidence strongly supports continuing legal existence, County-contract significance, employer identity in important labor/wage records, physician corporate governance, and litigation significance.

What is established:

• distinct juridical existence;

• professional-corporation status;

• continued current contracting/employer roles;

• physician officers/directors;

• formal professional authority under the MSA.

What is not established:

• exact current shareholder roster;

• exact historical share percentages;

• exact CFMG stock-transfer terms;

• who can compel transfer or replacement of physician ownership.

Formal professional reservations#

The MSA expressly preserves a professional-corporation structure. CFMG retains professional medical authority and meaningful functions involving physician staffing, clinical quality, credentialing, corrective action, impaired-physician matters, and policies of a purely medical character. The manager is not authorized to practice medicine.

These provisions are real contrary evidence to any categorical theory that CFMG had no professional role.

December 31, 2012 Management Services Agreement#

An executed Management Services Agreement dated December 31, 2012 is the most important structural document identified so far.

The agreement contains substantial language favoring legality:

• CFMG and the management company are described as separate independent entities.

• CFMG formally employs or engages physicians.

• Professional medical services and medical judgment are reserved to CFMG.

• The management company is prohibited from itself practicing medicine or directly assuming patient-care responsibility.

• The relationship is framed as administrative support rather than professional control.

Those provisions must be given genuine weight.

At the same time, the agreement creates a deeply integrated administrative relationship. The management company is made CFMG's exclusive management-services provider and receives broad responsibilities involving:

• accounting and financial administration;

• payroll and tax functions;

• employee and physician benefit administration;

• physician-employment documentation and policy administration;

• human-resources support;

• staffing analysis;

• physician compensation administration and recommendations;

• billing and coding support;

• information technology;

• electronic health-record systems and operational records;

• county/client contracting support;

• compliance and licensing support;

• insurance and risk-management functions;

• litigation support;

• purchasing and equipment administration;

• banking and budgeting;

• participation in governance-related processes.

This combination—formal reservation of physician authority plus extensive management-company operational authority—is the structural issue that must be tested against actual conduct.

Why the stock-transfer document is different from the MSA#

The Management Services Agreement tells us who administers the business.

The stock-transfer agreement may tell us who ultimately controls the owner of the medical corporation.

That distinction is fundamental.

A lawful MSO can perform extensive administrative services for an independently controlled medical corporation.

Examples may include:

• payroll;

• accounting;

• IT;

• HR administration;

• insurance;

• procurement;

• billing;

• compliance support;

• scheduling support;

• records infrastructure;

• contracting support.

The physician corporation can remain substantively independent if the physician owners retain real authority over professional matters and meaningful governance power over the corporation.

A stock-transfer instrument becomes more consequential because it can affect the person who holds the legal voting stock.

If the MSO merely prevents an unqualified person from inheriting professional-corporation stock and provides an orderly mechanism for transfer to another independently selected qualified physician, the agreement may function as a legitimate compliance and continuity device.

If, by contrast, the MSO can decide who owns the PC, replace the owner at will, or cause the owner to lose stock for challenging the MSO, then the agreement can give the MSO leverage over every decision formally assigned to the physician owner.

The legal inquiry therefore changes from:

“Who performs management services?”

to:

“Who can remove the person who is supposed to control the professional corporation?”

The 2012 management-agreement baseline#

Earlier articles in this series identified the December 31, 2012 Management Services Agreement as the central structural instrument in the modern CFMG–MSO arrangement.

The reviewed project record attributes to that agreement several provisions favoring a lawful PC–MSO architecture:

• CFMG and the management organization are described as separate entities;

• CFMG formally employs or engages physicians;

• professional medical services and medical judgment are reserved to CFMG;

• the management organization is not itself to practice medicine or assume direct patient-care responsibility;

• broad administrative services are delegated to the management side.

The same record describes the management organization as having extensive responsibilities concerning:

• payroll and benefits administration;

• physician-employment documentation;

• HR support;

• staffing analysis;

• compensation administration and recommendations;

• billing and coding support;

• IT and electronic-record systems;

• insurance and risk;

• litigation support;

• contracting;

• purchasing and equipment;

• finance, banking, and budgeting;

• and participation in governance-related processes.

A project submission that reviewed the executed agreement also identifies a potentially important “Company Designee” mechanism, under which certain CFMG actions or approvals may be communicated through a designated CFMG officer or designee and relied upon by the management organization as CFMG action.

That mechanism is not inherently improper. But it makes authentication of the approval chain essential. If CFMG decisions were routinely transmitted through one designee, the investigation must know:

• who held that role at each relevant time;

• whether the designee was a licensed physician;

• what authority had been delegated;

• whether professional decisions could be delegated at all;

• what record showed the underlying physician decision;

• and whether the MSO could act without obtaining a fresh CFMG approval.

The MSA therefore provides the formal hypothesis. the prior analysis tests whether actual conduct matched it.

Evidentiary caution: the standalone executed 2012 MSA has not yet been separately indexed in the current saved Library under an obvious filename. the investigation's existing section-by-section crosswalk should be treated as a strong retrieval guide, while the executed agreement, exhibits, assignments, amendments, and designee records remain Tier-One authentication targets.

The California litigation record does not support a single, simple proposition that CFMG and Wellpath are either “the same company” or “completely separate.”

It supports a more disciplined set of propositions that operate at different legal levels.

First, CFMG and Wellpath are legally distinct entities.

Post-bankruptcy litigation makes this unusually clear. Multiple matters had to correct earlier assumptions and add CFMG as a separate non-debtor party after Wellpath's Chapter 11 made entity identity legally consequential.

Second, legal separateness did not prevent extensive operational integration.

Discovery records, stipulations, employment testimony, claims/defense arrangements, shared administrative systems, and county descriptions repeatedly show Wellpath functioning through or alongside CFMG in HR, records, finance, litigation, claims, systems, and other administrative domains.

Third, some litigation positions expressly embraced functional sameness in particular contexts.

The strongest example is \_Smith v. Santa Cruz County\_, where CFMG participated in a case-specific stipulation treating CFMG and Wellpath as the same entity “for all intents and purposes,” and the district court later held CFMG to the breadth of the position it had requested for that litigation.

Fourth, other litigation positions later emphasized separateness.

\_Post-bankruptcy\_ cases such as \_Pugh\_, \_J.S.\_, and \_Reynolds\_ expressly identified CFMG as “separate and distinct” from Wellpath LLC and added or substituted CFMG because Wellpath's bankruptcy revealed that the California professional corporation had not simply disappeared into the debtor enterprise.

Fifth, those positions are not inherently contradictory.

A professional corporation can be a distinct juridical entity while sharing records systems, HR support, insurance, defense, administrative staff, branding, and financial infrastructure with an MSO. The litigation-to-control question is therefore not “Which label is true?” It is:

What control proposition was actually at issue in each case, what source supports it, and how far can the proposition legitimately be carried?

Sixth, the litigation record is much stronger for certain control domains than others.

The record is presently strongest for:

• juridical separateness;

• operational integration;

• HR participation;

• records/discovery integration;

• insurance/indemnity and defense infrastructure;

• public/client identity confusion;

• and context-dependent corporate descriptions.

It is materially weaker for:

• actual CFMG physician veto;

• final clinical-policy approval;

• physician workload override;

• referral/diagnostic authority;

• privileging;

• peer review;

• and the final decision chain for clinically sensitive physician-employment actions.

Seventh, no reviewed California case has been identified as adjudicating that Wellpath unlawfully exercised CFMG's physician-reserved authority under California's corporate-practice rules.

The litigation record contains direct evidence, sworn testimony, stipulations, discovery positions, and structural facts relevant to that question, but it should not be converted into a CPOM merits judgment that does not exist.

The principal synthesis of the prior analysis is:

California litigation proves legal separateness and substantial operational integration at the same time. It also proves that the companies and their counsel have described that relationship differently depending on the function and procedural context. The remaining CPOM question is not resolved by those labels. It depends on the decision rights isolated in earlier articles in this series.

A. Core defense narrative#

CFMG is a California professional medical corporation that remained legally distinct from Wellpath and formally employed physicians. Wellpath and predecessor management entities supplied the extensive administrative infrastructure that allows a statewide correctional medical practice to function: payroll, benefits, HR support, information technology, credentialing administration, contracting support, insurance/risk, claims, litigation support, purchasing, finance, and related services.

The 2012 Management Services Agreement was deliberately structured to reserve professional medical services and physician judgment to CFMG while prohibiting the manager from practicing medicine or directly assuming patient-care responsibility. The management company was not pretending to be a hospital or a medical group. It was an MSO.

The fact that administrative functions became highly centralized after the 2018 Wellpath merger does not convert the MSO into the medical corporation.

The best direct evidence for that proposition includes:

• CFMG's continued separate legal existence;

• post-bankruptcy stipulations and orders treating CFMG as separate from Wellpath;

• quarterly DE 9 and DE 9C wage reports identifying the reporting entity, which would establish the same proposition from a public filing — not located in the public record for this project;

• sworn testimony that CFMG pays its employees;

• the Fresno County contract structure;

• contemporaneous professional-employment decision records showing which entity exercised the authority — not located in the public record for this project;

• and the unresolved public question of how CFMG physician-governance bodies are constituted, delegated, and documented in practice.

The defense therefore says:

the investigation has proved administrative integration, not unlawful displacement of physician authority.

IV. Contrary Evidence, Limits, and Competing Explanations#

A disciplined analysis must begin its limiting case with the strongest contrary evidence: Counterevidence to any simple narrative includes CFMG's continued legal existence, the distinction between enterprise transactions and PC shares, and the fact that later branding can obscure rather than replace juridical identity.

V. Missing Documents and Falsification Tests#

The record remains incomplete in material respects. Key unresolved points include exact corporate succession, historical ownership, and whether later enterprise changes altered only management or also professional-corporation governance.

Right-to-Leave#

CFMG has real termination rights for qualifying breach and specified insolvency events. It is therefore inaccurate to say CFMG had “no right to leave.” The practical question is whether it could replace Wellpath while remaining economically, operationally, and professionally viable given long duration, renewal, management systems, financing, claims/insurance, HR/payroll, IT/EHR, records, County obligations, and the still-missing ownership/succession instruments.

This produces the controlling question:

Could CFMG replace Wellpath as manager without losing the ability to function as the County-contracted professional corporation?

ARTICLE V.F MAY CARRY RELATED AGREEMENTS WITH THE ASSUMED MSA, within limits#

Article V.F is especially interesting for the stock-control inquiry.

The Plan says that, unless otherwise provided, an assumed executory contract includes all modifications, amendments, supplements, restatements, or other agreements that in any manner affect the contract, together with related executory contracts and leases, rights, privileges, options, rights of first refusal, and other interests, unless those agreements were separately rejected.

Placed beside the January 2019 Assignment, which transferred the CFMG MSA together with related/incidental instruments including relevant stock-transfer restriction agreements, it creates a plausible legal pathway by which related instruments could continue with the assumed management relationship.

But the record must not jump too far. The current record does not establish that a particular CFMG Stock Transfer Agreement was itself executory, that Article V.F definitively assumed that exact document, that no separate treatment applied, or that every stock-control right survived unchanged.

The correct proposition is:

The Plan’s broad related-agreements provision makes continuation of MSA-linked instruments legally plausible and increases the importance of determining whether the CFMG stock-transfer agreement was separately scheduled, rejected, amended, or treated as an organizational document.

That remains a high-priority source question.

VI. Why the Issue Matters#

The stakes are practical rather than semantic. Counties need to know which entity is accountable for contracted performance; clinicians need to know where professional authority resides; courts and regulators need entity-specific evidence rather than brand shorthand; and the public needs a record that distinguishes corporate continuity from operational integration. Those distinctions become most important when the actors disagree, when a contract changes hands, when a professional decision conflicts with an economic preference, or when litigation requires a precise answer to who had authority to act.

California’s PC–MSO Boundary: What the Law Actually Protects#

California does not prohibit physicians from using management companies. It does prohibit unlicensed persons and ordinary corporations from taking over professional medical authority. The hard question is where administration ends and professional control begins.

That distinction is central to understanding CFMG and Wellpath.

A management-services organization can perform extensive business functions for a medical practice. Payroll, technology, accounting, benefits, contracting support, facilities and administrative staff do not become the practice of medicine simply because a non-physician organization handles them.

But California’s rule is not limited to bedside diagnosis.

The state’s own Medical Board identifies several “business” decisions as potentially constituting control over medical practice when they determine how physicians practice.

That makes the CFMG–Wellpath investigation a question of decision rights , not merely corporate ownership or branding.

The 2012 MSA creates a long-term exclusive management relationship#

The December 31, 2012 MSA makes the management company CFMG's exclusive provider of Management Services .

The initial term lasted ten years.

Afterward, the agreement automatically renews for successive five-year terms unless terminated under the agreement's specified termination provisions.

A long-term exclusive MSA is not inherently improper.

Healthcare practices commonly enter long-term arrangements for:

• billing;

• HR;

• IT;

• finance;

• facilities;

• contracting;

• compliance;

• insurance;

• procurement.

The structural question is whether exclusivity, when combined with the other provisions, leaves the professional corporation capable of changing managers in practice.

A ten-year initial term followed by automatic five-year renewals increases the importance of:

• termination rights;

• exit costs;

• information portability;

• employee portability;

• financing consequences;

• asset ownership;

• contractual assignment rights.

VII. Falsification Tests and Evidentiary Limits Note#

The record does not support be read as establishing an unproven motive, an undisclosed shareholder, an unlawful medical override, or a legal conclusion that a court or regulator has not made. The strongest version of the thesis is the one that survives the missing-document test: identify the instrument, minutes, ledger, delegation, approval record, or disagreement event that would materially change the conclusion, then state what has and has not been found. If later primary evidence contradicts a proposition stated here, the correction should be made at the proposition level rather than defended through branding or organizational shorthand.

VIII. Related Articles#

• Article 001 — CFMG Before Wellpath: The California Correctional-Health Corporation That Predated the Brand

• Article 003 — H.I.G. Enters the CFMG Enterprise: What the 2013 Investment Proves—and What It Does Not

IX. Clause-by-clause charging analysis of the 2012 MSA#

The 2012 Management Services Agreement should be analyzed the way a prosecutor would analyze a complex delegation instrument: not by asking whether it is “broad,” but by identifying which powers are affirmatively transferred, which are expressly reserved, which are shared, and which become meaningful only when paired with another agreement. That method avoids both common errors in this record. It avoids treating every administrative service as unlawful medical control, and it avoids assuming that a contractual reservation of clinical authority proves that the reservation was effective in practice.

The first category is the professional reservation. The agreement describes CFMG as the California professional corporation and states that CFMG retains control over professional medical services and the methods by which physicians practice medicine. That language is important because California's corporate-practice framework is concerned with control over professional judgment, not with the mere existence of business services. On its face, the contract is drafted to preserve that boundary.

The second category is the exclusive management grant. The manager receives a wide operational role involving finance, accounting, payroll administration, benefits, recruiting support, records systems, information technology, contracting support, insurance, claims, and related infrastructure. Those functions can be extensive and economically consequential without being the practice of medicine. But their breadth creates leverage. If the professional corporation depends on the manager for virtually every nonclinical system necessary to operate, then the practical ability to exercise a reserved right may depend on whether the corporation can obtain those services elsewhere.

That produces a distinction between legal reservation and operational portability. A clause can reserve final physician staffing authority to CFMG while the manager controls recruiting pipelines, compensation administration, scheduling infrastructure, and financial modeling. The reservation remains legally meaningful, but a real dispute would require evidence of what happened when the manager's recommendation and the professional corporation's judgment diverged. The same analysis applies to clinical-policy support, credentialing administration, records, and quality systems.

The third category is economic integration. A long-term exclusive management relationship, combined with management fees, cash-management systems, financial support, insurance, and administrative infrastructure, can create strong alignment. Alignment is not itself unlawful. The relevant question is whether economic dependence became a mechanism for overriding physician-reserved decisions. That cannot be inferred from a fee percentage or a centralized bank account alone. It requires a conflict record: who proposed the action, who objected, who had authority to decide, and whose decision was implemented.

The fourth category is the set of related agreements referred to by later assignment and bankruptcy materials. The 2019 assignment's reference to stock-transfer restriction instruments matters because ownership and succession are the areas where a formally compliant PC-MSO structure can be tested most directly. The MSA may tell the reader that CFMG controls medicine. A stock-transfer agreement may reveal who can become the shareholder, under what conditions a shareholder must sell, and whether the manager or an affiliate possesses contractual influence over succession. Those instruments therefore cannot be treated as mere appendices.

The Company Designee problem#

The agreement's allocation of powers also makes the identity and authority of the “Company Designee” significant. A delegated representative can be entirely consistent with physician governance if the designee acts under authority granted by the professional corporation and remains accountable to it. The same title becomes more consequential if the designee is selected, removable, or directed by the management side. The public record therefore needs the historical appointment documents, the identity of each designee, the scope of each delegation, and any record showing how disagreements were escalated.

A defense-oriented reading would emphasize that sophisticated healthcare organizations routinely create delegated interfaces so that an MSO can act efficiently without practicing medicine. An enforcement-oriented reading would ask whether the interface became the place where the manager effectively made decisions that the written agreement reserved to physicians. Both readings are plausible until the appointment and conflict records are examined.

Right-to-Leave is the contract's practical stress test#

The contract should also be tested at its exit provisions. Formal termination rights are meaningful only if the professional corporation can survive their exercise. If termination would leave CFMG without staff systems, payroll, EHR access, insurance support, billing, county interfaces, or transition services, practical dependence may be far greater than the text suggests. Conversely, if the agreement provides workable transition rights, data portability, cooperation, and the ability to retain county contracts while replacing the manager, that is strong evidence of genuine separateness.

This is why a serious brief should not describe the 2012 MSA as either exculpatory or incriminating in the abstract. The document is better understood as a map of the intended boundary. The factual investigation begins where that map meets actual operations.

Evidentiary findings#

High confidence: the MSA deliberately separates professional medicine from management services and assigns the manager a very broad operational portfolio. High confidence: the breadth of that portfolio makes the manager central to CFMG's business operations. Moderate confidence: the agreement creates conditions in which administrative leverage could become relevant to professional independence if a conflict arose. Not established by the MSA alone: that such leverage was actually used to override a physician-reserved decision.

The decisive missing proof remains concrete and auditable: shareholder and succession records; Company Designee appointments; termination and transition records; conflict-tested physician votes; and examples in which a management recommendation was rejected and the professional decision nevertheless controlled implementation. Those records would tell the reader whether the contract's professional reservation was merely textual or institutionally effective.

X. Seven operational domains in which the MSA can be tested#

The agreement becomes more useful when its abstractions are converted into operational domains. Physician staffing is one: the manager may analyze needs and make recommendations, while the professional corporation is described as retaining final authority. Physician compensation is another: finance and market information may come from the manager, but compensation decisions touching professional services must be traced to the legally authorized actor. Clinical policy is a third: enterprise experts may draft or recommend policy, but the record should show who adopts it for the California professional corporation. Credentialing and competence form a fourth: administrative processing can be centralized while professional judgments about competence remain reserved. Quality and peer review form a fifth: data systems and committees may be enterprise-wide, but physician-specific consequences raise professional-governance questions. Medical records and information systems form a sixth: ownership, custody, access, and portability of data can affect both compliance and exit. Finance and contracting form a seventh: the manager may perform extensive business functions without becoming the professional decision-maker.

For each domain, the same four-document test can be applied. First, identify the governing clause. Second, identify any policy or delegation implementing that clause. Third, locate a real decision in which the function was exercised. Fourth, compare the formal decision-maker with the person who made the first operative decision. That sequence is more probative than organizational charts because it tests conduct rather than titles.

The MSA's sophistication cuts both ways. For the defense, detailed reservations and allocation clauses show that the parties recognized California's professional boundary and attempted to draft around it lawfully. For an investigator, the same specificity means there should be records showing how the boundary operated. If the agreement says CFMG makes the final staffing decision, one should be able to find approvals, minutes, or communications demonstrating that process. If the manager is only to recommend, the record should reveal examples in which a recommendation was modified or rejected.

Exclusivity is not illegality, but it raises the value of the exit evidence#

An exclusive management relationship can be commercially rational. It permits investment in systems, standardization, and centralized services. But exclusivity also makes termination provisions and transition rights more probative. If CFMG can terminate for breach yet cannot obtain its own data, continue payroll, maintain insurance, or transition county contracts, the formal termination right may be difficult to exercise. If the agreement provides orderly transition obligations and CFMG can select a replacement manager, the independence account becomes stronger.

The analysis therefore must avoid using “exclusive” as a loaded adjective. The relevant question is what exclusivity does when the parties disagree. Does it simply prevent CFMG from using two managers at once, or does it make the manager practically irreplaceable? The answer lies in the complete agreement, related instruments, and evidence of any attempted or contemplated transition.

A contract drafted to comply can still be tested for implementation#

California corporate-practice analysis is not satisfied by pointing only to text or only to integration. The more persuasive legal method is congruence: does actual conduct match the allocation the contract represents? If yes, the MSA is strong evidence of a lawful PC-MSO structure. If no, the discrepancy becomes the investigative fact requiring explanation.

That congruence test should drive the rest of the series. The 2012 agreement is not merely historical background; it is the benchmark against which later staffing, employment, quality, policy, ownership, and exit evidence should be measured. Every later article that questions practical control should identify the MSA provision implicated and the evidence showing whether conduct conformed to it.

The MSA should be treated as a constitution with an implementation record#

A management agreement of this breadth is best understood as an operating constitution. It allocates powers, but it does not itself show how often those powers were invoked, how disputes were resolved, or whether the parties respected the allocation under pressure. That is why implementation records matter as much as the contract text.

A strong defense record would contain recurring documentary signatures of compliance: physician approvals before clinical-policy implementation; CFMG decisions on physician staffing and competence; board or committee minutes showing professional deliberation; and examples in which the manager's recommendation was not adopted. A strong enforcement record would look different: implementation preceding professional approval, management personnel making the first operative professional decision, or economic and employment mechanisms being used to force a clinical outcome.

The distinction is especially important because most days produce no conflict. Routine cooperation cannot prove who would prevail if interests diverged. The best evidence therefore comes from exceptions—expensive staffing decisions, disputed clinical policies, physician-specific discipline, termination of management services, or succession of the professional owner. Those events expose whether the written allocation is durable.

Accordingly, the 2012 MSA should not be summarized merely as “CFMG controls medicine; the manager controls business.” Its real evidentiary value is that it creates a set of testable propositions. Each later article in the series should identify which proposition it tests and whether the public record confirms, complicates, or contradicts the contractual baseline.

Conclusion#

Article 002 should be published only at the level of confidence the record supports. The controlling proposition is the one stated in the question presented above; adjacent issues such as ownership, employer status, professional authority, bankruptcy treatment, and branding should remain separate unless a primary source supplies the bridge. The strongest contrary evidence belongs in the article, not in an editorial footnote, and any unresolved ownership, delegation, succession, or decision-chain record should remain identified as a document target rather than converted into a factual assertion.

How each source is used#

The following public authorities are tied to defined propositions in this article. They are not interchangeable: each is cited for the institutional purpose it can actually prove, and none is treated as a universal finding about ownership, employment, liability, or professional control.

• 2012 CFMG Management Services Agreement — California Forensic Medical Group, Incorporated and California Forensic Management Group, Inc., Dec. 31, 2012. Used here as operative baseline for the allocation of management functions, physician-reserved responsibilities, and the manager/professional-corporation relationship.
• 2019 Assignment of Management Services Agreement, effective Jan. 1, 2019 — CFMG remained the Company while Wellpath LLC became the Manager. Used here as dated evidence of management succession without, by itself, eliminating CFMG's separate professional-corporation identity.
• Medical Board of California, Practice Information / Corporate Practice of Medicine guidance. Used here as California regulator guidance identifying physician-reserved decisions and limits on delegation of professional judgment to management organizations.
• California Business and Professions Code § 2400. Used here as the statutory anchor for California's prohibition on the unlicensed corporate practice of medicine.
• California Corporations Code § 13401.5, Moscone-Knox Professional Corporation Act. Used here as the professional-corporation ownership and licensed-person framework relevant to shareholder, director, officer, and professional-employee questions.
• California Attorney General, Apr. 1, 2026, amicus announcement defending California's corporate-practice-of-medicine prohibition in Art Center Holdings. Used here as a current California enforcement position emphasizing rights of control over professional functions, not merely formal labels.

Sources and authorities#

1. 2012 CFMG Management Services Agreement — California Forensic Medical Group, Incorporated and California Forensic Management Group, Inc., Dec. 31, 2012 — https://www.prisonlegalnews.org/news/publications/california-forensic-medical-group-incorporated-management-services-agreement/
2. 2019 Assignment of Management Services Agreement, effective Jan. 1, 2019 — CFMG remained the Company while Wellpath LLC became the Manager — https://www.prisonlegalnews.org/media/publications/California\_Forensic\_Medical\_Group\_Assignment\_of\_Management\_Services\_Agreement.pdf
3. Medical Board of California, Practice Information / Corporate Practice of Medicine guidance — https://www.mbc.ca.gov/Licensing/Physicians-and-Surgeons/Practice-Information/
4. California Business and Professions Code § 2400 — https://leginfo.legislature.ca.gov/faces/codes\_displaySection.xhtml?lawCode=BPC&sectionNum=2400.
5. California Corporations Code § 13401.5, Moscone-Knox Professional Corporation Act — https://leginfo.legislature.ca.gov/faces/codes\_displaySection.xhtml?lawCode=CORP&sectionNum=13401.5.
6. California Attorney General, Apr. 1, 2026, amicus announcement defending California's corporate-practice-of-medicine prohibition in Art Center Holdings — https://oag.ca.gov/news/press-releases/attorney-general-bonta-files-amicus-brief-defense-california%E2%80%99s-ban-corporate

Citation rule: These sources support only the propositions identified in the article and source analysis. A party filing remains a party position unless adopted by a court; a corporate announcement remains a corporate representation; a contract proves allocated rights but not necessarily implementation; and a regulator's guidance or enforcement position is not an adjudication against CFMG unless a cited matter says so.